Identification of microRNA-mRNA dysregulations in paroxysmal atrial fibrillation

- We analyzed the transcriptomic and microRNA changes associated with the early stage of atrial fibrillation in patients.
- We discovered 113 mRNAs and 49 miRNAs that were dysregulated in paroxysmal AF patients.
- We discovered 23 pairs of putative microRNA-mRNA dysregulations in paroxysmal AF patients.
- We identified new pathways implicated in the early stage of AF pathogenesis.

BackgroundThe molecular mechanisms underlying the early development of atrial fibrillation (AF) remain poorly understood. Emerging evidence suggests that abnormal epigenetic modulation via microRNAs (miRNAs) might be involved in the pathogenesis of paroxysmal AF (pAF).ObjectiveTo identify key molecular changes associated with pAF, we conducted state-of-the-art transcriptomic studies to identify the abnormal miRNA-mRNA interactions potentially driving AF development.MethodsHigh-quality total RNA including miRNA was isolated from atrial biopsies of age-matched and sex-matched pAF patients and control patients in sinus rhythm (SR; n = 4 per group) and used for RNA-sequencing and miRNA microarray. Results were analyzed bioinformatically and validated using quantitative real-time (qRT)-PCR and 3′UTR luciferase reporter assays.Results113 genes and 49 miRNAs were differentially expressed (DE) in pAF versus SR patients. Gene ontology analysis revealed that most of the DE genes were involved in the “gonadotropin releasing hormone receptor pathway” and “p53 pathway”. Of these DE genes, bioinformatic analyses identified 23 pairs of putative miRNA-mRNA interactions that were altered in pAF (involving 15 miRNAs and 17 mRNAs). Using qRT-PCR and 3′UTR luciferase reporter assays, the interaction between upregulation of miR-199a-5p and downregulation of FKBP5 was confirmed in samples from pAF patients.ConclusionOur combined transcriptomic analysis and miRNA microarray study of atrial samples from pAF patients revealed novel pathways and miRNA-mRNA regulations that may be relevant in the development of pAF. Future studies are required to investigate the potential involvement of the gonadotropin releasing hormone receptor and p53 pathways in AF pathogenesis.